Most just lately, it's been discovered that conolidine and the above derivatives act over the atypical chemokine receptor 3 (ACKR3. Expressed in very similar regions as classical opioid receptors, it binds to a wide array of endogenous opioids. Contrary to most opioid receptors, this receptor functions like a scavenger https://nilesd197zbo4.wikissl.com/user